Sono-Tek Q1 FY2027 revenue up 10% to $5.66M; net income up 53% to $741K

SONO TEK CORP

Gross margin expanded to 57% from 52%; operating income up 86% to $897K.
Medical sales surged to $3.95M (vs. $809K) on stent and drug-eluting balloon systems.
Backlog $7.73M; cash & equivalents $16.65M with no debt.
FY2027 full-year revenue expected flat to modestly higher; H1 growth driven by medical.
Multi-Axis coating system sales tripled to $2.08M; In-Line systems declined to $2.16M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.